PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555551
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555551
The market for Endoscopic Submucosal Dissection was projected to reach USD 355.6 million in 2023 and expand at a CAGR of 5.90% between 2024 - 2032.
A sophisticated endoscopic technique called Endoscopic Submucosal Dissection (ESD) is used to precisely and completely remove gastrointestinal lesions or tumors that are in their early stages. This procedure is minimally invasive. Larger, superficial lesions that would ordinarily need invasive surgery can be removed with this treatment. In order to access the damaged area during ESD, a specialized endoscope is inserted via mouth or anus. Once inside, a variety of electrosurgical tools and methods are used to lift and dissect the lesion from the submucosal layer. Compared to traditional surgery, ESD has a number of benefits, including shorter hospital stays, fewer postoperative problems, and better patient outcomes.
Endoscopic Submucosal Dissection Market- Market Dynamics
Increased Prevalence of Gastrointestinal Disorders
One major factor propelling the endoscopic submucosal dissection (ESD) market upward is the increased prevalence of gastrointestinal disorders, particularly colorectal and stomach cancers. The use of endoscopic submucosal dissection as the main treatment for gastrointestinal malignancies in their early stages is growing. For instance, the third most common cause of cancer-related death worldwide is stomach cancer, with approximately a million incident cases reported each year. Between 15 and 57 percent of occurrence cases of gastric cancer are Early Gastric Cancers (EGCs). The 5-year relative survival rates for stomach cancer vary depending on the stage: 75% is for localized stomach cancer (the cancer is limited to the stomach), 35% is for regional stomach cancer, and 7% is for metastatic stomach cancer. When compared to standard surgery, ESD is preferred because it can achieve en-bloc resections and reduce the rate of recurrence. It is predicted that this trend will hold, supporting market expansion.
Endoscopic Submucosal Dissection Market- Key Insights
According to our research analyst's analysis, the global market is projected to expand at a CAGR of approximately 5.90% during the forecast period of 2024-2032.
On the basis of indication, the stomach cancer category was projected to have the largest market share in 2023.
On the basis of product, the knives category emerged as the top segment in 2023.
North America held the largest revenue share by region in 2023.
The Global Endoscopic Submucosal Dissection Market is segmented into Indication, Product, End-user, and Region.
On the basis of indication, the market is segmented into Stomach Cancer, Esophageal Cancer, and Colon Cancer. The stomach cancer category held the largest market share in 2023. Globally increasing awareness and early diagnosis of illnesses, coupled with the increasing incidence of stomach cancer, created a demand for sophisticated treatment approaches such as electrosurgical decontamination (ESD), which enables the precise removal of malignant lesions from the stomach lining with little invasiveness. In the United States, there will be roughly 26,890 new instances of stomach cancer in 2024, according to estimates from the American Cancer Society. Additionally, patients' desire for less painful treatments with quicker recovery periods has fueled a trend toward less intrusive procedures, which supports the use of ESD for stomach cancer.
On the basis of product, the market is segmented into Gastroscopes And Colonoscopes, Tissue Retractors, Knives, Graspers/Clips, Injection Agents, and Others. With a 30% market share in 2023, the knives category is predicted to expand at the quickest rate of compound annual growth (CAGR) over the forecast period. Since knives are essential to the accuracy and precision of sample handling and preparation during chromatographic operations, it is no surprise that they dominate this market. In addition, the use of cutting-edge chromatographic instruments, such as knives, is encouraged by the rising expenditure in research and development across a range of sectors. There is an increasing need for high-performance knives as labs look to improve their analytical skills and productivity. The HYBRIDknife flex, for instance, is a CE-marked tool used in colorectal endoscopic submucosal dissection (ESD) that Erbe Elektromedizin introduced in August 2023.
Endoscopic Submucosal Dissection Market- Geographical Insights
The Endoscopic Submucosal Dissection market is widely distributed geographically in North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. These areas are further separated based on the countries that provide business.
With a revenue share of more than 35% in 2023, the North American endoscopic submucosal dissection (ESD) market-led because of the region's sophisticated healthcare infrastructure, high healthcare spending, and a strong emphasis on technical innovation. The area is fortunate to have a sizable patient population with a high incidence of malignancies and gastrointestinal problems, which calls for sophisticated therapeutic and diagnostic techniques. Furthermore, partnerships between medical professionals, academic institutions, and business leaders foster ongoing improvements in surgical methods.
Robust regulations, advancements in technology, and rising healthcare costs distinguish the European market for endoscopic submucosal dissections (ESDs). Numerous nations in the region have universal healthcare programs, which provide widespread access to cutting-edge medical treatments like ESD. Demand is driven by the high incidence of aging populations and the growing incidence of gastrointestinal cancers, including colorectal and stomach cancers. In order to give physicians top-notch supplies for Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), and Gastrointestinal (GI) tract endoscopic procedures, Penlon Limited established a new endoscopic accessories division in the UK in July 2023. The company partnered with Vedkang Medical to accomplish this.
There are a number of well-known international market participants as well as several up-and-coming businesses in this somewhat competitive market. A number of strategic initiatives, including mergers and acquisitions, technological collaborations, partnerships, and product launches, are being developed by market players like CONMED Corporation, Olympus Corporation, Boston Scientific Corporation, Oreo Medical, Medtronic PLC, and others in order to broaden their business reach into developing economies and attract a larger customer base.
April 2024: The Endoscopic Submucosal Dissection (ESD) Tracmotion device was introduced by Fujifilm during a gastroenterology event. The tool's 360° rotating retraction capability, which is intended for single-operator use, enables accurate tissue manipulation.
October 2023: Olympus announced the EVIS X1 system, along with endoscopes compatible with the CF-HQ1100DL/I and GIF-1100 series, marking the company's most recent innovation in gastrointestinal endoscopy. In order to improve lesion and polyp visibility during endoscopic screenings, this next-generation system uses Color Enhancement Imaging technology, which enhances image color and texture.
January 2023: The FushKnife and ClutchCutter are two cutting-edge endoscopic technologies that Fujifilm India unveiled. During endoscopic submucosal dissection (ESD) and EMR operations, doctors can execute accurate incision, dissection, and coagulation with these state-of-the-art tools that are compatible with endoscopes.